Wird geladen...
Anticoagulation Strategies in Patients With Cancer
Patients with active cancer are at an increased risk of arterial and venous thromboembolism (VTE) and bleeding events. Historically, in patients with cancer, low molecular weight heparins have been preferred for treatment of VTE, whereas warfarin has been the standard anticoagulant for stroke preven...
Gespeichert in:
| Veröffentlicht in: | J Am Coll Cardiol |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7957366/ https://ncbi.nlm.nih.gov/pubmed/30898209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2019.01.017 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|